Transfemoral Transcatheter Tricuspid Valve Replacement Using the EVOQUE System in an Octogenarian for Severe Tricuspid Valve Regurgitation.
evoque
transcatheter approach
transcatheter intervention
transcatheter tricuspid valve
transcatheter valve replacement
tricuspid prosthesis
tricuspid valve insufficiency
tricuspid valve regurgitation
Journal
Cureus
ISSN: 2168-8184
Titre abrégé: Cureus
Pays: United States
ID NLM: 101596737
Informations de publication
Date de publication:
Sep 2023
Sep 2023
Historique:
accepted:
24
09
2023
medline:
26
10
2023
pubmed:
26
10
2023
entrez:
26
10
2023
Statut:
epublish
Résumé
Tricuspid regurgitation is a frequent condition that is linked to an elevated risk of cardiovascular events and significant mortality but is often overshadowed by left-sided valve diseases. Isolated surgical tricuspid valve surgery is still considered a high-risk surgery, and over recent years, various transcatheter procedures for tricuspid treatment have emerged as an alternative solution. Among the available transcatheter procedures, the EVOQUE system's transcatheter tricuspid valve replacement could potentially offer a solution, especially in patients considered non-eligible for transcatheter edge-to-edge tricuspid valve repair. We present a case report of an octogenarian patient considered at prohibitive risk for conventional surgery and not eligible for transcatheter edge-to-edge repair who was eventually treated with a transfemoral transcatheter tricuspid 52-mm EVOQUE valve implantation. Postprocedural recovery and follow-up at 18 months were uneventful, with a well-functioning tricuspid valve bioprosthesis.
Identifiants
pubmed: 37881383
doi: 10.7759/cureus.45848
pmc: PMC10594838
doi:
Types de publication
Case Reports
Langues
eng
Pagination
e45848Informations de copyright
Copyright © 2023, Cuko et al.
Déclaration de conflit d'intérêts
The authors have declared that no competing interests exist.
Références
J Thorac Cardiovasc Surg. 2006 Dec;132(6):1258-61
pubmed: 17140937
JACC Cardiovasc Interv. 2022 Mar 14;15(5):492-495
pubmed: 35272773
J Am Coll Cardiol. 2004 Feb 4;43(3):405-9
pubmed: 15013122
Circulation. 2019 Jul 16;140(3):196-206
pubmed: 31117814
JACC Cardiovasc Interv. 2021 Mar 8;14(5):501-511
pubmed: 33582084
JACC Cardiovasc Interv. 2020 May 25;13(10):e93-e94
pubmed: 32171717
JACC Cardiovasc Interv. 2019 Jan 28;12(2):155-165
pubmed: 30594510
J Am Coll Cardiol. 2023 Jun 20;81(24):2374-2376
pubmed: 37191592
JACC Cardiovasc Interv. 2019 Aug 12;12(15):1451-1461
pubmed: 31395215
JACC Cardiovasc Imaging. 2019 Mar;12(3):433-442
pubmed: 30121261
J Am Heart Assoc. 2017 Dec 22;6(12):
pubmed: 29273638
JACC Cardiovasc Interv. 2022 Mar 14;15(5):471-480
pubmed: 35272771
JACC Cardiovasc Interv. 2022 Mar 14;15(5):481-491
pubmed: 35272772
J Am Coll Cardiol. 2017 Dec 19;70(24):2953-2960
pubmed: 29241483
Circ Cardiovasc Interv. 2023 Aug;16(8):e012888
pubmed: 37582170
JACC Cardiovasc Imaging. 2014 Dec;7(12):1185-94
pubmed: 25440592
Eur Heart J. 2013 Mar;34(11):844-52
pubmed: 23335604
Int J Cardiol. 2023 Oct 15;389:131194
pubmed: 37473817
Eur Heart J. 2018 Oct 14;39(39):3574-3581
pubmed: 30010848
Eur Heart J. 2020 Dec 1;41(45):4304-4317
pubmed: 32974668